Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia
for
Friedreich Ataxia
Location: Eatontown NJ, Philadelphia PA, Chevy Chase MD,
Sponsor: Larimar Therapeutics, Inc.
Sex: All
Age: 2 - 60
Code: NCT06447025
Phase 2, Recruiting
Clinical Trials of Multivalent Opioid Vaccine Components
for
Opioid-use Disorder
Location: Eatontown NJ
Sponsor: New York State Psychiatric Institute
Sex: All
Age: 18 - 59
Code: NCT04458545
Phase 1, Phase 2, Recruiting
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
for
Sleep Deprivation
Location: Eatontown NJ
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18 - 55
Code: NCT07848659
Phase 1, Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
for
Excessive Sleepiness, Shift-work Disorder
Location: Middletown NJ, Wyomissing PA, Towson MD, Boston MA,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06568367
Phase 3, Recruiting
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: West Long Branch NJ, Silver Spring MD, New Albany IN,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT07430306
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
for
Advanced Solid Tumor
Location: New Brunswick NJ, Boston MA, Fairfax VA, San Antonio TX
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07128303
Phase 1, Recruiting
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
for
Negative Symptoms of Schizophrenia
Location: New York NY, Marlton NJ, Gaithersburg MD, Decatur GA,
Sponsor: Minerva Neurosciences
Sex: All
Age: 18 - 55
Code: NCT07565428
Phase 3, Recruiting
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Grand Rapids MI, Jacksonville FL,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT07424833
Phase 1, Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
for
Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer,
Location: East Brunswick NJ, Fairfax VA, Miami FL, Springdale AR,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07625644
Phase 3, Recruiting
Visugromab in Cachexia International Trial
for
Cancer-associated Cachexia
Location: East Brunswick NJ, Norwich CT, Mayfield Heights OH,
Sponsor: CatalYm GmbH
Sex: All
Age: 18+
Code: NCT07112196
Phase 2, Phase 3, Recruiting
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
for
Breast Cancer
Location: East Brunswick NJ, Jacksonville FL, Kansas City MO,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07368998
Phase 2, Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: East Brunswick NJ, Boston MA, Fairfax VA, Nashville TN,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase 1, Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: Robbinsville NJ, Philadelphia PA, Milford MA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 12 - 17
Code: NCT06979453
Phase 3, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, c-MET
Location: East Brunswick NJ, Lebanon NH, Brampton, Fort Wayne IN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07155187
Phase 2, Phase 3, Recruiting
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
for
Locally Advanced Solid Tumor
Location: East Brunswick NJ, Dallas TX, Los Angeles CA
Sponsor: Fortvita Biologics (USA)Inc.
Sex: All
Age: 18+
Code: NCT06349408
Phase 1, Recruiting
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
for
Extensive-stage Small Cell Lung Carcinoma,
Location: East Brunswick NJ
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07843940
Phase 1, Phase 2, Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Location: East Brunswick NJ, Philadelphia PA, York PA,
Sponsor: Guardant Health, Inc.
Sex: All
Age: 18+
Code: NCT05059444
Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
for
Non Small Cell Lung Carcinoma, c-MET
Location: East Brunswick NJ, Easton PA, Shirley NY, Boston MA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06772623
Phase 1, Phase 2, Recruiting
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Location: East Brunswick NJ, New York NY, Mullica Hill NJ,